These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18814071)

  • 1. Laboratory testing for lupus anticoagulants: diagnostic criteria and use of screening, mixing, and confirmatory studies.
    Tripodi A
    Semin Thromb Hemost; 2008 Jun; 34(4):373-9. PubMed ID: 18814071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory testing for lupus anticoagulants: pre-examination variables, mixing studies, and diagnostic criteria.
    Ledford-Kraemer MR
    Semin Thromb Hemost; 2008 Jun; 34(4):380-8. PubMed ID: 18814072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing for lupus anticoagulants: all that a clinician should know.
    Tripodi A
    Lupus; 2009 Apr; 18(4):291-8. PubMed ID: 19276296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid syndrome: laboratory testing and diagnostic strategies.
    Ortel TL
    Am J Hematol; 2012 May; 87 Suppl 1(Suppl 1):S75-81. PubMed ID: 22473619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 119(3):369-76. PubMed ID: 16704874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence of false negative screening for lupus anticoagulants.
    Moore GW; Henley A; Greenwood CK; Rangarajan S
    Thromb Res; 2008; 121(4):477-84. PubMed ID: 17602725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
    Galli M
    Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory identification of lupus anticoagulants.
    Kershaw G; Suresh S; Orellana D; Nguy YM
    Semin Thromb Hemost; 2012 Jun; 38(4):375-84. PubMed ID: 22573409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conceptions and misconceptions in testing for lupus anticoagulants.
    Exner T
    J Autoimmun; 2000 Sep; 15(2):179-83. PubMed ID: 10968906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of heparin in samples submitted for lupus anticoagulant testing.
    Sangle NA; Rodgers GM; Smock KJ
    Lab Hematol; 2011 Mar; 17(1):6-11. PubMed ID: 21421539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory identification of lupus anticoagulants.
    Smock KJ; Rodgers GM
    Am J Hematol; 2009 Jul; 84(7):440-2. PubMed ID: 19384933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome].
    Ieko M; Naito S; Yoshida M
    Rinsho Byori; 2009 Oct; 57(10):990-8. PubMed ID: 19928497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices.
    Moffat KA; Ledford-Kraemer MR; Plumhoff EA; McKay H; Nichols WL; Meijer P; Hayward CP
    Thromb Haemost; 2009 Jan; 101(1):178-84. PubMed ID: 19132206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests.
    Zhang L; Whitis JG; Embry MB; Hollensead SC
    Am J Clin Pathol; 2005 Dec; 124(6):894-901. PubMed ID: 16416739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5.
    Jacobsen EM; Barna-Cler L; Taylor JM; Triplett DA; Wisløff F
    Thromb Haemost; 2000 May; 83(5):704-8. PubMed ID: 10823266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A consensus approach to the formulation of guidelines for laboratory testing and reporting of antiphospholipid antibody assays.
    Wong RC; Favaloro EJ
    Semin Thromb Hemost; 2008 Jun; 34(4):361-72. PubMed ID: 18814070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the reagent "IL Test LAC Screen/IL Test LAC Confirm" for the biological diagnosis of circulating lupus anticoagulants].
    Magdelaine A; Verdy E
    Ann Biol Clin (Paris); 1996; 54(7):293-6. PubMed ID: 8952726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory diagnostic outcome applying detection criteria recommended by the Scientific and Standardization Committee of the ISTH on Lupus Anticoagulant.
    Chantarangkul V; Biguzzi E; Asti D; Palmucci C; Tripodi A
    Thromb Haemost; 2013 Jul; 110(1):46-52. PubMed ID: 23615569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.